These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 14511941)
1. Nesiritide in acute heart failure. de Moraes Barros GD; de Carvalho Leite CR Lancet; 2003 Sep; 362(9388):999. PubMed ID: 14511941 [No Abstract] [Full Text] [Related]
2. Plasma cardiac natriuretic peptide levels in screening for cardiac disease. Nicholls MG; Obineche EN; Frampton CM; Richards AM Am J Med; 2004 Apr; 116(8):561-3. PubMed ID: 15063820 [No Abstract] [Full Text] [Related]
3. The relationship between tumor necrosis factor-α, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failure. Vaz Pérez A; Doehner W; von Haehling S; Schmidt H; Zimmermann AV; Volk HD; Anker SD; Rauchhaus M Int J Cardiol; 2010 May; 141(1):39-43. PubMed ID: 19155075 [TBL] [Abstract][Full Text] [Related]
4. Is nesiritide really that good or that bad? Cheng TO Am Heart J; 2006 Apr; 151(4):e1; author reply e3. PubMed ID: 16569525 [No Abstract] [Full Text] [Related]
5. Nesiritide is beneficial or harmful to patients with decompensated acute congestive heart failure. Ma X; Sun F; Ma J Int J Cardiol; 2015; 187():387-8. PubMed ID: 25841132 [No Abstract] [Full Text] [Related]
6. Use of nesiritide in critically ill children with biventricular dysfunction suffering from oliguria despite standard heart-failure management. Das BB; Koch J; Dimas V; Guleserian K; Nugent A Cardiol Young; 2016 Apr; 26(4):819-23. PubMed ID: 26694972 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure. McCullough PA; Kuncheria J; Mathur VS Rev Cardiovasc Med; 2003; 4 Suppl 7():S3-S12. PubMed ID: 14668695 [TBL] [Abstract][Full Text] [Related]
14. The lost decade of nesiritide. Topol EJ N Engl J Med; 2011 Jul; 365(1):81-2. PubMed ID: 21732841 [No Abstract] [Full Text] [Related]
15. Use of nesiritide to treat acute decompensated heart failure. Hachey DM; Smith T Crit Care Nurse; 2003 Feb; 23(1):53-5. PubMed ID: 12640959 [No Abstract] [Full Text] [Related]
16. Nesiritide: harmful or harmless? Dorsch MP; Rodgers JE Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657 [TBL] [Abstract][Full Text] [Related]
17. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction. Riter HG; Redfield MM; Burnett JC; Chen HH J Am Coll Cardiol; 2006 Jun; 47(11):2334-5. PubMed ID: 16750705 [No Abstract] [Full Text] [Related]
18. Nesiritide in acute decompensated heart failure: to use or not to use, that is the question? Kapoor JR Am J Cardiol; 2007 Aug; 100(4):745-6. PubMed ID: 17697845 [No Abstract] [Full Text] [Related]
19. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment. Munger MA; Ng TM; Van Tassell BW Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695 [TBL] [Abstract][Full Text] [Related]
20. Nesiritide speeds recovery time for heart failure patients. Morrow T Manag Care; 2004 Jul; 13(7):60-1. PubMed ID: 15347161 [No Abstract] [Full Text] [Related] [Next] [New Search]